| Labatec Pharma SA - Levosimendan Labatec 12.5 mg/5 ml, solution à diluer pour perfusion |
| 69551 | | 01 | | Levosimendan Labatec 12.5 mg/5 ml | | solution à diluer pour perfusion | | C01CX08 | | Levosimendan | | 10.07.2024 | | |
|
| Composition |
| levosimendanum 12.5 mg, povidonum K 12, ethanolum anhydricum 3.945 g, acidum citricum, ad solutionem pro 5 ml, corresp. ethanolum 99 % V/V. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| Levosimendanum | 12.5mg / 5ml |
| | | | Inactive agents | Dose |
|---|
| Citric Acid | | | Ethanol Anhydrate | 3.945g / 5ml | | Povidonum K | 12 |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | PR | PR | A | | No |
|
